Buscador de noticias

E.g., 25/08/2024
E.g., 25/08/2024
About the CNIC
29 Jan 2020

Dr. Valentín Fuster’s group will contribute to the iMAP project through the PESA-CNIC-Santander study

About the CNIC
12 Dec 2019

Professor Jacob Fog Bentzon from Aarhus University and the CNIC  receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis – one of the most frequent causes of death in the world

About the CNIC
30 Oct 2019

One of the diseases most affected by aging is cardiovascular illness. In fact, it is already considered the most important risk factor for this disease


About the CNIC
30 Oct 2019

The project aims to study how certain mutations acquired in blood cells and traditionally associated with a high risk of developing leukemia can also contribute to the development of cardiovascular disease and become a new and independent cardiovascular risk factor to classical factors

About the CNIC
18 Sep 2019

Dra. Ivana Nikolić studies the role of T cells in the development of diseases associated with obesity

About the CNIC
16 Jul 2019

Dr. Valentín Fuster will be teaching the summer seminar series “Molecular, Clinical & Population Bases of Cardiovascular Disease and Health”, organized by the  International University Menéndez Pelayo (UIMP) and the Icahn School of Medicine at Mount Sinai.

About the CNIC
12 Jun 2019

EMBO promotes excellence in scientific research, and one of its major goals is to support talented researchers at all stages of their careers

About the CNIC
6 May 2019

Image: In the picture, individual endothelial cells have different fluorescent barcodes and mitogenic stimulations, allowing the non-invasive fate-mapping of their proliferative and migratory behaviours over time.

About the CNIC
3 Apr 2019
  • Adiponectin, secreted by adipose tissue, protects against the development of the main form of liver cancer
  • Women produce the hormone in larger quantities than men, and adiponectin release also declines in people with obesity
  • The results open the route to combating a cancer for which there is currently no treatment and that is the fourth cause of death in the world.